The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 23, 2021
Filed:
Jan. 11, 2018
Applicant:
Eli Lilly and Company, Indianapolis, IN (US);
Inventors:
Michael Patrick Akers, Indianapolis, IN (US);
Michael Edward Christe, Pendleton, IN (US);
Thomas Andrew Hardy, Carmel, IN (US);
Ranajoy Majumdar, Indianapolis, IN (US);
Chi Arch Nguyen, Fishers, IN (US);
Chad Donald Paavola, Indianapolis, IN (US);
Virender Kumar Sarin, Carmel, IN (US);
Nanette Elizabeth Schulte, Indianapolis, IN (US);
Assignee:
Eli Lilly and Company, Indianapolis, IN (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/28 (2006.01); A61K 47/12 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 9/00 (2006.01); A61K 31/192 (2006.01); A61K 47/34 (2017.01);
U.S. Cl.
CPC ...
A61K 38/28 (2013.01); A61K 9/0019 (2013.01); A61K 31/192 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/34 (2013.01);
Abstract
The invention is a pharmaceutical composition of human insulin or insulin analog that includes citrate, treprostinil and stabilizing agents, that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products and that is stable for commercial use.